Embedded Files
Huntington disease
Huntington disease (HD) is a lethal inherited neurodegenerative disease, which causes neuronal degeneration in specific brain areas (basal ganglia, prefrontal cortex). HD is characterized by involuntary sporadic motor movements (chorea) along with depression, and cognitive deficits of which symptoms worsen as the disease progresses. There is presently no cure for HD and the current treatment options can only alleviate the symptoms associated with HD. In 2008, tetrabenazine was approved by the FDA to control the motor symptoms associated with the disease. Drug development for Huntington disease is ongoing and you can keep up with the latest development at:
The Huntington society of Canada
-http://huntingtonsociety.ca/
Alzheimer Disease
Alzheimer Disease is the most common form of dementia affecting more than 500’000 Canadians. The greatest risk factor for Alzheimer is aging where the risk factor increasing drastically after the age of 65 of which two thirds affected are women.
There is currently no cure for AD but the current treatment options aim to slow the progression of the disease or alleviate symptoms associated with the disease. This makes it easier to treat these individuals and improves the patient quality of life along with the family’s care. For the latest updates on treatment options and drug development for Alzheimer’ disease, consult:
The Alzheimer society of Canada
-http://www.alzheimer.ca/en
Page updated
Google Sites
Report abuse